Product: | Imatinib | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 17521 | ||||||||
CAS Number: | 152459-95-5 | ||||||||
Pricing: |
|
||||||||
Formula: | C29H31N7O | ||||||||
Chemical Purity: | 98% | ||||||||
Molecular Weight: | 493.60 | ||||||||
Structure: | |||||||||
Category: | Anti-cancer compounds | ||||||||
Literature References: |
Goldman JM, Melo JV, Chronic myeloid leukemia – advances in biology and new approaches to treatment. N. Engl. J. Med., 2003, 349 (15): 1451–64.; Stegmeier F, Warmuth M, Sellers WR, Dorsch M., Targeted cancer therapies in the twenty-first century: lessons from imatinib. Clin. Pharmacol. Ther., 2010, 87 (5): 543–52. |
||||||||
MSDS: | |||||||||
Applications: | A tyrosine-kinase inhibitor. Used to treat multiple cancers such as, chronic myelogenous leukemia and gastrointestinal stromal tumors. |